Digital biomarkers enhance clinical assessments and monitoring in neurology and psychiatry, suggesting improved patient insights.
The digital biomarkers that have emerged from advances in digital technologies are expected to transform diagnostics and monitoring in the fields of neurology and psychiatry. Applications are being explored in various contexts, such as motor assessments in neurodegenerative diseases and behavioral tracking in psychiatric disorders. Moreover, digital biomarkers have already been used as endpoints in clinical trials. Combining these objective digital measures with conventional clinical assessments is likely to contribute to a more comprehensive understanding of patients.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: